Viewing Study NCT04047524


Ignite Creation Date: 2025-12-18 @ 8:11 AM
Ignite Modification Date: 2025-12-18 @ 8:11 AM
Study NCT ID: NCT04047524
Status: None
Last Update Posted: 2019-08-20 00:00:00
First Post: 2019-07-15 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trimodal Prehabilitation Study for Patients Undergoing Major Abdominal Surgery
Sponsor: None
Organization:

Study Overview

Official Title: Trimodal Prehabilitation Programme Using Smart Watches and Mobile Applications in Patients Undergoing Major Abdominal Surgery: a Randomised Controlled Pilot Study
Status: None
Status Verified Date: 2019-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: 30 patients due to undergo major abdominal cancer surgery at The Christie NHS Foundation Trust will be enrolled to a pilot randomised controlled trial. They will randomised to either a home-based trimodal prehabilitation programme, delivered by the use of FitBit Smart Watches and Smartphone applications, or a control group who will receive a FitBit for physical activity monitoring only, for a period of 2-6 weeks prior to surgery. The prehabilitation programme will include exercise, nutritional, and psychological components. Study outcomes will include 6MWT (6-minute walk test), HADS (hospital anxiety and depression score), steps per day, length of stay post-operatively, and post-operative complications.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: